NCT03729115View on ClinicalTrials.gov

A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer

NARecruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

May 30, 2019

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Breast Cancer
Interventions
PROCEDURE

Magnetic Resonance Imaging (MRI)

Patients will have MRI scans every 6 months.

Trial Locations (1)

60637

RECRUITING

University Of Chicago Medicine Comprehensive Cancer Center, Chicago

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Chicago

OTHER

NCT03729115 - A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer | Biotech Hunter | Biotech Hunter